Literature DB >> 17537523

Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.

Babs O Fabriek1, Holger J Møller, Rianka P M Vloet, Lisa M van Winsen, Roeland Hanemaaijer, Charlotte E Teunissen, Bernard M J Uitdehaag, Timo K van den Berg, Christine D Dijkstra.   

Abstract

The scavenger receptor CD163 is selectively expressed on tissue macrophages and human monocytes. CD163 has been implicated to play a role in the clearance of hemoglobin and in the regulation of cytokine production by macrophages. Membrane CD163 can be cleaved by matrix metalloproteinases (MMP) resulting in soluble CD163 (sCD163). In the present report the shedding of CD163 was investigated in multiple sclerosis (MS). An upregulation of plasma sCD163 and a down regulation of membrane CD163 in MS patients compared to healthy controls was observed. The levels of plasma sCD163 correlated with plasma MMP-9 levels in controls, but not in MS patients. Moreover, evidence was obtained for CD163-cleaving MMP activity in plasma of MS patients. Finally, the increased proteolytic shedding of CD163 correlated to reduced plasma levels of circulating inflammatory cytokines. Collectively, our results provide evidence for proteolytic shedding of CD163 in MS and suggest a possible link to cytokine production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537523     DOI: 10.1016/j.jneuroim.2007.04.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

Review 1.  Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans.

Authors:  Kenneth Williams; Tricia H Burdo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-14       Impact factor: 4.147

2.  Increased serum levels of soluble CD163 in patients with scleroderma.

Authors:  Kazuhiro Shimizu; Fumihide Ogawa; Ayumi Yoshizaki; Yuichiro Akiyama; Yutaka Kuwatsuka; Shihoko Okazaki; Hajime Tomita; Motoi Takenaka; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2012-03-29       Impact factor: 2.980

3.  Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.

Authors:  Emma Tippett; Wan-Jung Cheng; Clare Westhorpe; Paul U Cameron; Bruce J Brew; Sharon R Lewin; Anthony Jaworowski; Suzanne M Crowe
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

4.  Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.

Authors:  M C González-Oria; M Márquez-Coello; J A Girón-Ortega; J Argente; M Moya; José-Antonio Girón-González
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-16       Impact factor: 4.147

5.  Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.

Authors:  Catherine Ingels; Holger J Møller; Troels K Hansen; Pieter J Wouters; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  J Clin Immunol       Date:  2012-11-13       Impact factor: 8.317

6.  HIV Infection Is Associated with Loss of Anti-Inflammatory Alveolar Macrophages.

Authors:  Charles Preston Neff; Shaikh M Atif; Eric C Logue; Janet Siebert; Carsten Görg; James Lavelle; Suzanne Fiorillo; Homer Twigg; Thomas B Campbell; Andrew P Fontenot; Brent E Palmer
Journal:  J Immunol       Date:  2020-09-14       Impact factor: 5.422

Review 7.  The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights.

Authors:  Zoya Qaiyum; Melissa Lim; Robert D Inman
Journal:  Semin Immunopathol       Date:  2021-02-24       Impact factor: 11.759

8.  Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.

Authors:  Eleonora Franzè; Roberta Caruso; Carmine Stolfi; Massimiliano Sarra; Maria Laura Cupi; Flavio Caprioli; Ivan Monteleone; Francesca Zorzi; Daniela De Nitto; Alfredo Colantoni; Livia Biancone; Francesco Pallone; Giovanni Monteleone
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

9.  Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis.

Authors:  Morten Stilund; Ann-Kathrin Reuschlein; Tove Christensen; Holger Jon Møller; Peter Vestergaard Rasmussen; Thor Petersen
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

10.  A multi-biomarker follow-up study of patients with multiple sclerosis.

Authors:  Morten Stilund; Mikkel Carstensen Gjelstrup; Tove Christensen; Holger Jon Møller; Thor Petersen
Journal:  Brain Behav       Date:  2016-07-11       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.